2
R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation
plus
Actualités sur Health
Odyssey Announces Agreement to Combine with BenevolentAI
London and Amsterdam (ots/PRNewswire) - - BenevolentAI is a leading, clinical-stage AI drug discovery company that combines advanced AI and machine learning with cutting edge science to discover and develop novel and more effective medicines - Combination of BenevolentAI with Odyssey, a EUR300m Euronext Amsterdam-listed special purpose acquisition company focused on European healthcare and technology, represents the ...
plusSchweizerischer Nationalfonds / Fonds national suisse
Innovative research into new vaccines
Bern (ots) - Projects taking part in the National Research Programme "Covid-19" (NRP 78) of the Swiss National Science Foundation (SNSF) are pursuing highly promising approaches in a drive to develop new vaccines. Three research groups have adopted interesting approaches to the highly topical issue of vaccines. The team led by Steve Pascolo is investigating ways of improving functionality and stability of mRNA vaccines, ...
plusThe Lancet Regional Health - Europe publishes 'real-world evidence' from ALK-sponsored study confirming long-term benefits of allergy immunotherapy in allergic rhinitis and asthma
Copenhagen, Denmark (ots/PRNewswire) - - Results from ALK-sponsored REACT (REAl-world effeCTtiveness of allergy immunotherapy) study have been published in The Lancet Regional Health - Europe - REACT demonstrated the real-world effectiveness of allergy immunotherapy (AIT) - including ALK products - in allergic ...
plusRóbert Wessman-led Aztiq and Innobic join forces in $475m acquisition of Lotus Pharmaceutical and Adalvo to create a global pharmaceutical powerhouse
Reykjavík, Iceland (ots/PRNewswire) - - The Aztiq-Innobic consortium will acquire a 100% stake in Alvogen Emerging Markets Holdings Limited, thereby becoming the leading shareholders in Lotus Pharmaceutical and the sole shareholder in Adalvo - Róbert Wessman, chairman and CEO of Alvogen and founder of Aztiq, will ...
plusUAE to receive award from Parliamentary Assembly of the Mediterranean for Waterfalls Initiative
Rome (ots/PRNewswire) - On Thursday November 18, in the Sala Protomoteca of the Campidoglio in Rome, the United Arab Emirates, represented by Saif bin Zayed, Deputy Prime Minister and Minister of the Interior received an award from the Parliamentary Assembly of the Mediterranean (PAM) for Waterfalls, a global ...
plus
Filterlex Medical Closes a $6Million Series A1 Investment to Accelerate the CAPTIS® Cardiovascular Clinical Program
Caesarea, Israel (ots/PRNewswire) - Filterlex Medical, a cardiovascular medical device startup, announced today that it has recently completed a US $6 Million series A1 investment round from leading private healthcare investors. The financing will accelerate implementation of the company's CAPTIS® clinical program. ...
plusFDI World Dental Federation: Prescribing of dental antibiotics up 22% in England during first year of COVID-19 / Prescriptions of all other antibiotics fell during the same period
plusAnteryon reports clear growth figures in a challenging year.
Eindhoven, The Netherlands (ots/PRNewswire) - Anteryon, a specialist in high-tech optical components, has helped its global customer base turn more ideas into solutions even during the past Covid year. The company reports crystal-clear growth figures and is set to continue growing at a rapid pace. Anteryon creates, develops and produces clear solutions for optical challenges. From its own competence centre, located at ...
plusHovione invests $170 million in new capacity and capabilities
Milan (ots/PRNewswire) - Hovione, the global leader in spray drying and particle engineering, today announced that it is expanding its industrial facilities around the world to support its ambitious growth objectives. The company has been on an expansion track since 2016 in Portugal, Ireland and New Jersey with the aim of continuing to increase its capacity and capabilities to address customer needs. The announcement of a ...
plusEssence SmartCare Wins CES 2022 Innovation Award for VitalOn Telehealth Platform
Herzliya, Israel (ots/PRNewswire) - System Recognized for Comprehensive Remote Patient Monitoring Capabilities and Chronic Conditions Management Addressing Wide Range of Healthcare Needs Essence SmartCare, a leader in IoT-based remote care solutions, part of Essence Group, today announced that it has been named a CES® 2022 Innovation Awards Honoree for the VitalOn ...
plusGenomics England; Queen Mary University of London (QMUL)
Whole genome sequencing improves diagnosis of rare diseases and shortens diagnostic journeys for patients, according to world first study
London (ots/PRNewswire) - NB: SCIENCE MEDIA BRIEFING TAKING PLACE 14:00 GMT 9TH NOVEMBER 2021 - whole genome sequencing proved to be a better way to diagnose rare diseases than usual genomic testing methods - whole genome sequencing led to new rare disease diagnoses for NHS patients in some cases ending decades-long ...
plus
Pfizer tops the CNS Summit Innovation Index
London (ots/PRNewswire) - The fifth annual ranking of digital, R&D and commercial partnership innovation in global pharma The fifth annual CNS Summit Innovation Index, compiled by IDEA Pharma, sees Pfizer top the industry. Released at the CNS Summit in Boston, MA, the CNS Summit Innovation Index examines which drug makers are leveraging innovation in three spheres: clinical development which sets the stage for future ...
plusEPI Health and MC2 Therapeutics Announce Wynzora® Cream (calcipotriene and betamethasone dipropionate w/w 0.005%/0.064%) now covered on Express Scripts National Preferred Formulary
Charleston, S.c. and Copenhagen, Denmark (ots/PRNewswire) - Wynzora® Cream (calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064%) for once-daily topical treatment of plaque psoriasis in adults 18 years of age or older. EPI Health, LLC, a specialty pharmaceutical company committed to delivering innovative ...
plusWegovy(TM) Demonstrated Significant and Sustained Weight Loss in Two-Year Study in Adults With Obesity
Bagsværd, Denmark (ots/PRNewswire) - - The STEP 5 trial demonstrated an average weight loss of 15.2% with Wegovy(TM) at 104-weeks when used with a reduced calorie meal plan and increased physical activity vs. 2.6% with placebo - The trial also showed that 77.1% of study participants who received Wegovy(TM) lost at ...
plusZentiva Advances Pharmaceutical Research Through ORBIS Project
Prague (ots/PRNewswire) - One of the missions that Zentiva has consistently pursued is to connect Academia and the Pharmaceutical Industry to accelerate drug development innovation and meet the unmet needs of the patients. Our company is pleased to resume the scientific exchange program as part of the ORBIS project, which was created within the largest EU grant programs HORIZON 2020, to connect European and American ...
plusAbcam; Nautilus Biotechnology, Inc.
As an element of Nautilus' overall reagent development and sourcing strategy, the partnership aims to accelerate research and development, and provide customers with access to Abcam's antibody development technology and expertise
Seattle and Cambridge, England (ots/PRNewswire) - Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, and Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences research tools, today announced a ...
plusthe International Diabetes Federation
Diabetes is "a pandemic of unprecedented magnitude" now affecting one in 10 adults worldwide, reveals the International Diabetes Federation
Brussels (ots/PRNewswire) - New figures from the International Diabetes Federation reveal that 537 million adults around the globe are living with diabetes The International Diabetes Federation (IDF) has released new figures showing that 537 million adults are now living with diabetes worldwide - a rise of 16% (74 ...
plus
Panoramix research project set out to evaluate the risk of chemical mixtures for human health
Brussels (ots/PRNewswire) - Panoramix (Providing risk assessments of complex real-life mixtures for the protection of European citizens and the environment), a 4-year project led by the Technical University of Denmark, focuses on innovative ways for quantifying the risk associated with exposure to chemical mixtures, without animal testing. The project is supported by ...
plusMindtree Launches Digital Health Passport for Travel to Improve Traveler Experience and Safety
Warren, N.j. and Bangalore, India (ots/PRNewswire) - Mindtree, a global technology services and digital transformation company, today launched Digital Health Passport for Travel, a solution that provides a smarter, safer and smoother experience to global travelers in navigating frequently changing travel regulations and restrictions related to the COVID-19 pandemic. ...
plusWorld Stroke Day: Global survey reveals only 35% hospitals worldwide provide essential stroke treatment
Geneva (ots/PRNewswire) - On World Stroke Day, 29 October, the World Stroke Organization (WSO) is calling for urgent action after a survey by the WSO and the World Health Organization (WHO) found that only 35% of hospitals worldwide provide essential clot-busting medicine tissue plasminogen activator (tPA), despite ...
plusRoche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes
Basel, Switzerland (ots/PRNewswire) - - Roche, a world leader in integrated Personalised Diabetes Management, and the Zur Rose Group, provider of a European digital healthcare ecosystem, announce their collaboration to improve everyday therapy management and better address the needs of 60 million people living with ...
plusRoche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes
Basel (ots) - - Roche, a world leader in integrated Personalised Diabetes Management, and the Zur Rose Group, provider of a European digital healthcare ecosystem, announce their collaboration to improve everyday therapy management and better address the needs of 60 million people living with diabetes in Europe [1] - ...
plusAbcam completes $340m strategic acquisition and expands kit capacity and capability
Cambridge, England (ots/PRNewswire) - - Completing $340m strategic acquisition of BioVision - Expanding facilities in Eugene, further growing kits and assays portfolio - Supporting the growing demand of the sector and accelerating execution of strategic plan Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today announces the ...
plus
The International Osteoporosis Foundation (IOF)
Action for bone health is needed now more than ever, urges IOF
plusCARB-X FUNDS THE 3RD ROUND OF DEBIOPHARM’S TARGETED ANTIBIOTIC PROGRAM TO COMBAT RESISTANT N. GONORRHOEAE INFECTIONS
Lausanne, Switzerland / Boston, USA (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company announced today having been awarded the third phase funding to advance the development of its antibiotic program, Debio 1453, by the Combating Antibiotic-Resistant Bacteria Biopharmaceutical ...
plusSeibersdorf Labor GmbH; Isotopia Molecular Imaging
Isotopia Molecular Imaging and Seibersdorf Labor GmbH Announce Production Agreement for 177Lu n.c.a.
Tel Aviv, Israel and Vienna, Austria (ots/PRNewswire) - Isotopia Molecular Imaging and Seibersdorf Labor are pleased to announce that they have entered into an agreement for the production of no-carrier-added Lutetium-177, a critical medical radioisotope used in the manufacturing of radiopharmaceuticals for ...
plusMicreos appoints Matt Regan as CEO of its Pharmaceutical business
The Hague, Netherlands (ots/PRNewswire) - Dutch biotechnology company Micreos has recruited Matt Regan as CEO of its new Pharmaceutical business that will be based in Switzerland. Following rapid growth, Micreos is preparing to spin-out its Pharmaceutical business into a separate company as per January 2022 to directly access the capital markets. This will help to fund pipeline development to progress its highly ...
plusNovaliq Receives EU Quality Management Certificate According To New Medical Device Regulation (MDR)
Heidelberg, Germany (ots/PRNewswire) - Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced that it has implemented and applies a quality management system in accordance with Annex IX, Chapter I of the EU ...
plusFresenius Kabi Deutschland GmbH
Fresenius Kabi at ESPEN Virtual Congress 2021: EuroPN Study will provide new clinical data on critical care nutrition
Bad Homburg, Germany (ots/PRNewswire) - Real-world-data on the medical nutrition practice in Intensive Care Units (ICU) for critically ill patients is limited so far. To close this knowledge gap, Fresenius Kabi started EuroPN Study in 2019 in eleven European countries with around 100 participating hospitals[1]. At ...
plus
Précédent6789101112131415Suivant